Kegiatan Pengabdian Masyarakat dalam Rangka Edukasi Masyarakat mengenai Hiperlipidemia serta Deteksi Dini Hiperlipidemia dan Kaitannya dengan Kejadian Obesitas
DOI:
https://doi.org/10.55606/pkmsisthana.v5i2.745Keywords:
Early detection, Education, Hyperlipidemia, Obesity, ScreeningAbstract
Hyperlipidemia is a metabolic disorder that indicates an increase in lipid levels in the body. Obesity, particularly central obesity, is correlated with hyperlipidemia and metabolic syndrome. Complications of hyperlipidemia such as coronary artery disease, type 2 diabetes, and high blood pressure can be fatal if left untreated. Education and early detection of hyperlipidemia are crucial to prevent serious complications and maintain good health. This community service involved 50 elderly at Santa Anna Elderly Care Facility. All respondents participated in a series of activities, including education through posters, physical examinations, and diagnostic tests. Results of the diagnostic tests indicated 2 respondents had LDL levels ? 135 mg/dL, 6 respondents had HDL levels < 40 mg/dL, and 12 respondents had total cholesterol levels ? 200 mg/dL. The results of the education activities are expected to increase public awareness, all of which can reduce the overall healthcare burden when applied correctly and properly.
References
Anitha, Seetha, Rosemary Botha, Joanna Kane-Potaka, D. Ian Givens, Ananthan Rajendran, Takuji W. Tsusaka, and Raj Kumar Bhandari. 2021. “Can Millet Consumption Help Manage Hyperlipidemia and Obesity?: A Systematic Review and Meta-Analysis.” Frontiers in Nutrition 8, no. August (August). https://doi.org/10.3389/fnut.2021.700778.
Chang, Chi-Jen, Deng-Yuan Jian, Ming-Wei Lin, Jun-Zhi Zhao, Low-Tone Ho, and Chi-Chang Juan. 2015. “Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity.” Edited by Jonathan Peterson. PLOS ONE 10, no. 5 (May): e0125935. https://doi.org/10.1371/journal.pone.0125935.
Ezeh, Kosisochukwu J, and Obiora Ezeudemba. 2021. “Hyperlipidemia: A Review of the Novel Methods for the Management of Lipids.” Cureus, July (July). https://doi.org/10.7759/cureus.16412.
Feng, Konglong, Xiaoai Zhu, Tong Chen, Bo Peng, Muwen Lu, Hui Zheng, Qingrong Huang, Chi-Tang Ho, Yunjiao Chen, and Yong Cao. 2019. “Prevention of Obesity and Hyperlipidemia by Heptamethoxyflavone in High-Fat Diet-Induced Rats.” Journal of Agricultural and Food Chemistry 67, no. 9 (March): 2476–89. https://doi.org/10.1021/acs.jafc.8b05632.
Hill, Marcus F., and Bruno Bordoni. 2023. Hyperlipidemia. StatPearls. StatPearls Publishing.
Karr, Samantha. 2017. “Epidemiology and Management of Hyperlipidemia.” The American Journal of Managed Care 23, no. 9 Suppl (June): S139–48.
Kihara, Shinji. 2013. “Dyslipidemia.” Nihon Rinsho. Japanese Journal of Clinical Medicine. https://doi.org/10.7326/aitc201712050.
Kim, Seung Jae, Oh. Deog Kwon, and Kyung-Soo Kim. 2021. “Prevalence, Awareness, Treatment, and Control of Dyslipidemia among Diabetes Mellitus Patients and Predictors of Optimal Dyslipidemia Control: Results from the Korea National Health and Nutrition Examination Survey.” Lipids in Health and Disease 20, no. 1 (December): 29. https://doi.org/10.1186/s12944-021-01455-3.
Nouh, Faiza, Mariam Omar, and Manal Younis. 2019. “Risk Factors and Management of Hyperlipidemia.” Asian Journal of Cardiology Research 2, no. 1: 1–10. https://doi.org/10.9734/AJCR/2019/45449.
Opoku, Sampson, Yong Gan, Emmanuel Addo Yobo, David Tenkorang-Twum, Wei Yue, Zhihong Wang, and Zuxun Lu. 2021. “Awareness, Treatment, Control, and Determinants of Dyslipidemia among Adults in China.” Scientific Reports 11, no. 1 (May): 10056. https://doi.org/10.1038/s41598-021-89401-2.
Sandesara, Pratik B, Salim S Virani, Sergio Fazio, and Michael D Shapiro. 2019. “The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.” Endocrine Reviews 40, no. 2 (April): 537–57. https://doi.org/10.1210/er.2018-00184.
Stewart, Jeremy, Tracy McCallin, Julian Martinez, Sheebu Chacko, and Shabana Yusuf. 2020. “Hyperlipidemia.” Pediatrics In Review 41, no. 8 (August): 393–402. https://doi.org/10.1542/pir.2019-0053.
Sugai, Takuro, Yutaro Suzuki, Manabu Yamazaki, Kazutaka Shimoda, Takao Mori, Yuji Ozeki, Hiroshi Matsuda, et al. 2016. “High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey.” Edited by Nanette H Bishopric. PLOS ONE 11, no. 11 (November): e0166429. https://doi.org/10.1371/journal.pone.0166429.
Vekic, Jelena, Aleksandra Zeljkovic, Aleksandra Stefanovic, Zorana Jelic-Ivanovic, and Vesna Spasojevic-Kalimanovska. 2019. “Obesity and Dyslipidemia.” Metabolism 92, no. March (March): 71–81. https://doi.org/10.1016/j.metabol.2018.11.005.
Zhang, Peng, Xin Sun, Hang Jin, Fu-Liang Zhang, Zhen-Ni Guo, and Yi Yang. 2020. “Association Between Obesity Type and Common Vascular and Metabolic Diseases: A Cross-Sectional Study.” Frontiers in Endocrinology 10, no. January (January). https://doi.org/10.3389/fendo.2019.00900.
